AAVG, AVII, SSHO Evening Stock Report !

LevelStock.com Newsletter

LevelStock.com Newsletter June 2nd 2010.

AvStar Aviation Group (Pinksheets:AAVG)

 

In Anticipation of Newest Acquisition, Twin Town Leasing Co. d/b/a Twin Air Calypso, AAVG Announces 25-Year Veteran of the Financial Industry as Newest Team Member

AAVG proudly announces the addition of Bradley R. Hollingsworth C.P.A., C.I.S.A., C.I.S.P. to the AAVG executive team. Mr. Hollingsworth's appointment comes on the heels of an amended LOI with Twin Air Calypso. Mr. Hollingsworth has over 25 years' combined management and financial industry experience. He has worked with major entities like UHY Advisors, SanFill Inc. and U.S. Liquids; also, he was an independent auditor, C.P.A. and EDGAR filer for many years. In his illustrious career he has proven a range of skills such as: Project management, Business Combination Analysis, Cash Flow Analysis, Data Conversion, EDGAR filings for the SEC, and most valuable to AAVG, his experience performing due diligence during major acquisitions. Now that the company is in the final phases of acquiring a new Fixed Base Operations (FBO) hub, Twin Air Calypso, AAVG is thankful to have such a valuable team member.

http://finance.yahoo.com/news/In-Anticipation-of-Newest-iw-1041378579.html?x=0&.v=1


Read More http://www.avstargroup.com/

__________________________________________________________

AVI BioPharma, Inc. (NASDAQ: AVII)

AVI-4658 Demonstrates First Ever Reported Generation of Greater Than 50% Dystrophin-Positive Muscle Fibers in a Patient Following Systemic Administration in Duchenne Muscular Dystrophy; All Patients in Two Highest Dose Cohorts Generated New Dystrophin-Positive Fibers

AVII a developer of RNA-based drugs, today announced topline biopsy data from Study 28, the ongoing Phase 1b/2 clinical trial of AVI-4658, AVI's lead drug candidate being developed as a systemically administered treatment for a substantial subgroup of patients with Duchenne muscular dystrophy (DMD), a genetic muscle wasting disease caused by failure to produce dystrophin. Topline biopsy data from the study demonstrated the first ever reported generation of new dystrophin-positive muscle fibers of more than 50% of normal in a patient with DMD following systemic administration of a drug. All patients in the two highest dose cohorts of the study demonstrated generation of new dystrophin-positive muscle fibers, although treatment responses varied across and within treatment groups. Generation of functional dystrophin is considered critical for successful treatment of DMD, and AVI intends further clinical evaluation of AVI-4658 to help optimize a dosing regimen to achieve more consistent improvements among patients.

http://finance.yahoo.com/news/AVI4658-Demonstrates-First-iw-1087013472.html?x=0&.v=1

 
Read More http://www.avibio.com/

____________________________________________________________________________


South Shore Resources Inc. SSHO.PK

SSHO could be called the driving force behind the automotive industry.

To the point, it lets you go further at less cost, when it comes to your vehicle. The company’s HyProStar Hybrid Conversion Kit uses proven technology to increase your mileage and significantly reduce your fuel costs. On most vehicles, SSHO’s HyProStar improves fuel economy up to 25% or more.

The problem with today’s internal combustion engines is that they are inefficient at converting gas into forward motion. According to industry experts, as much as 15-20 percent of the gasoline in your vehicle is converted to pollution and carbon deposits (unburned fuel).

SSHO’s HyProStar uses a little electricity from your car or truck battery to extract hydrogen from water. The hydrogen mixes with oxygen via the intake manifold and acts as a combustion enhancement for a better, more complete burn of fuel; which results in lower emissions, greatly improved mileage and more power for your vehicle.

SSHO is engaged in the manufacturing, marketing, sales and distribution of products which are committed to fuel savings with the use of Hydrogen Generating Modules and related accessories to the transportation and automotive manufacturing industries which are either in development and/or commercialization stages.

SSHO is now poised to commercialize its HyProStar Hydrogen Generator Hybrid Conversion Kit and bring it to the global market. With over 750 million automobiles currently using combustible engines world wide and the increased pressure to reduce greenhouse gases. SSHO is confident that now is the time to aggressively enter this market.

More about at www.southshoreresourcesinc.com

______________________________________________________________

 

  Stay Tuned. Happy Trading !

LevelStock.com